How do you pay?
How many tablets?

How to pay the least

Lowest price

$14.10 for 30 tablets

Generic spironolactone and hydrochlorothiazide 25 mg / 25 mg at Walgreens with the free Optum Perks coupon

What to do

  1. Get the free Optum Perks coupon from its page. There’s nothing to sign up for.Get the free Optum Perks coupon 
  2. Ask your prescriber to send the prescription to your nearest Walgreens. Or ask the store’s pharmacy to transfer it from your pharmacy.Find the nearest store 
  3. Show the coupon and ask for generic spironolactone and hydrochlorothiazide 25 mg / 25 mg. It can’t be used with insurance.

Other ways

Rather have it mailed? $18 for 30 tablets from Rx Outreach, by mail. Make a free account, then have your prescription sent there.

Open Rx Outreach 

A regular generic has the same active ingredient as Aldactazide, and the FDA requires it to work the same way.

See every pharmacy’s price

Compare every option

Brand name

Aldactazide itself isn’t sold as a prescription anymore.

Not soldNo longer sold

Authorized generic

The same medicine as Aldactazide, without the brand name

Cash priceAsk the pharmacyUsually among the lowest
How to ask for it

The NDC to ask for

The same medicine as Aldactazide, without the brand name. Its NDC is the number that names the exact product: give it to the pharmacy and they can look it up or order it.

Sold as

spironolactone and hydrochlorothiazide

Sold by
  • Prasco Laboratories
  1. Give the pharmacy this NDC

    • 25 mg / 25 mgtablet
      • 66993-188-02Same number, 11 digits: 66993-0188-02100 tablets per bottle
  2. What to say at the pharmacy

    “Before you fill my Aldactazide, can you tell me what I’d pay for the brand, for the authorized generic from Prasco Laboratories (NDC 66993-188-02), and for a regular generic?”

    Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

Source: FDA, updated November 16, 2026

Brand and authorized generic labels

Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).

Aldactazide itself isn’t sold anymore, so there’s no current brand label to compare. Here’s the authorized generic’s label.

Authorized genericPrasco Laboratories
See the ingredients

Active: spironolactone 25 mg · hydrochlorothiazide 25 mg

Inactive:

  • Calcium sulfate
  • Ferric oxide red
  • Hydroxypropyl cellulose
  • Hypromellose
  • Magnesium stearate
  • Polyethylene glycol
  • Povidone
  • Corn starch
  • Titanium dioxide

Regular generic

Same active ingredient as Aldactazide. Fillers and dyes can differ.

Cash price$14.10for 30 tablets at Walgreens + Optum Perks
Where to buy it and who makes it

Where to buy it

Pharmacies’ own cash prices for generic spironolactone and hydrochlorothiazide, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Who makes it

3 companies sell a generic of Aldactazide that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Mylan Institutional25 mg / 25 mg

    Has lactose · Has dyes: D&C Yellow No. 10 aluminum lake, FD&C Yellow No. 6

    How it looks, what’s in it, NDCs

    25 mg / 25 mg Ivory, round, 10 mm, marked “M / 41”

    PackageNDC
    Carton of 10042292-017-20

    Inactive ingredients: silicon dioxide, lactose monohydrate, menthol form, magnesium stearate, microcrystalline cellulose 102, peppermint oil, sodium lauryl sulfate, sodium starch glycolate type a potato, starch, corn, D&C Yellow No. 10 aluminum lake, FD&C Yellow No. 6

    FDA label

  • Mylan Pharmaceuticals25 mg / 25 mg

    Has lactose · Has dyes: D&C Yellow No. 10 aluminum lake, FD&C Yellow No. 6

    Product page on viatris.com

    How it looks, what’s in it, NDCs

    25 mg / 25 mg Ivory, round, 10 mm, marked “M / 41”

    PackageNDC
    Bottle of 1000378-0403-01
    Bottle of 5000378-0403-05

    Inactive ingredients: silicon dioxide, lactose monohydrate, menthol form, magnesium stearate, microcrystalline cellulose 102, peppermint oil, sodium lauryl sulfate, sodium starch glycolate type a potato, starch, corn, D&C Yellow No. 10 aluminum lake, FD&C Yellow No. 6

    FDA label

  • Sun Pharmaceutical Industries25 mg / 25 mg

    Has lactose · Has dyes: D&C Yellow No. 10, FD&C Yellow No. 6

    How it looks, what’s in it, NDCs

    25 mg / 25 mg Off-white, buff, round, 10 mm, marked “MP / 40”

    PackageNDC
    Bottle of 10053489-144-01
    Bottle of 50053489-144-05
    Bottle of 100053489-144-10

    Inactive ingredients: anhydrous lactose, silicon dioxide, D&C Yellow No. 10, docusate sodium, FD&C Yellow No. 6, magnesium stearate, microcrystalline cellulose, peppermint, povidone, sodium benzoate, sodium starch glycolate type a potato

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Spironolactone, an ingredient of spironolactone and hydrochlorothiazide tablets, has been shown to be a tumorigen in chronic toxicity studies in rats (see Precautions section). Spironolactone and hydrochlorothiazide tablets should be used only in those conditions described below. Unnecessary use of this drug should be avoided.

Spironolactone and hydrochlorothiazide tablets are indicated for:

Edematous conditions for patients with:

Congestive heart failure:

  • For the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures;
  • The treatment of diuretic-induced hypokalemia in patients with congestive heart failure when other measures are considered inappropriate;
  • The treatment of patients with congestive heart failure taking digitalis when other therapies are considered inadequate or inappropriate.

Cirrhosis of the liver accompanied by edema and/or ascites:

  • Aldosterone levels may be exceptionally high in this condition. Spironolactone and hydrochlorothiazide tablets are indicated for maintenance therapy together with bed rest and the restriction of fluid and sodium.

The nephrotic syndrome:

  • For nephrotic patients when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics do not provide an adequate response.

Essential hypertension:

  • For patients with essential hypertension in whom other measures are considered inadequate or inappropriate;
  • In hypertensive patients for the treatment of a diuretic-induced hypokalemia when other measures are considered inappropriate;
  • Spironolactone and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the classes to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with spironolactone and hydrochlorothiazide tablets.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Usage in Pregnancy

The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developing toxemia.

Edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. Spironolactone and hydrochlorothiazide tablets are indicated in pregnancy when edema is due to pathologic causes just as it is in the absence of pregnancy (however, see Precautions: Pregnancy ). Dependent edema in pregnancy, resulting from restriction of venous return by the expanded uterus, is properly treated through elevation of the lower extremities and use of support hose; use of diuretics to lower intravascular volume in this case is unsupported and unnecessary. There is hypervolemia during normal pregnancy which is not harmful to either the fetus or the mother (in the absence of cardiovascular disease), but which is associated with edema, including generalized edema, in the majority of pregnant women. If this edema produces discomfort, increased recumbency will often provide relief. In rare instances, this edema may cause extreme discomfort that is not relieved by rest. In these cases, a short course of diuretics may provide relief and may be appropriate.

Source: the FDA label for Spironolactone and Hydrochlorothiazide (Prasco Laboratories), February 10, 2026. Full label on DailyMed 

Good to know

  • It may look different from Aldactazide (color, shape, or markings). That’s normal for an authorized generic.
  • If your prescription says “dispense as written,” the pharmacy needs your prescriber’s OK to give you the authorized generic.
  • Cash prices can differ a lot from one pharmacy to the next, so it can pay to ask two. With insurance, what you pay depends on your plan.
  • If your pharmacy doesn’t stock it, they can often order it within a day or two.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.